Jacob van Naarden - 13 Aug 2025 Form 4 Insider Report for ELI LILLY & Co (LLY)

Role: EVP & Pres., Lilly Oncology
Signature: /s/ Jonathan Groff for Jacob Van Naarden, pursuant to authorization on file
Issuer symbol: LLY
Transactions as of: 13 Aug 2025
Net transactions value: +$647,360
Form type: 4
Filing time: 13 Aug 2025, 16:15:45 UTC
Previous filing: 12 Feb 2025
Next filing: 03 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Van Naarden Jacob	EVP & Pres., Lilly Oncology	LILLY CORPORATE CENTER, INDIANAPOLIS	/s/ Jonathan Groff for Jacob Van Naarden, pursuant to authorization on file	13 Aug 2025	0001661254

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LLY	Common Stock	Purchase	$647,360	+1,000	+5.1%	$647.36	20,562	13 Aug 2025	Direct
holding	LLY	Common Stock						4,342	13 Aug 2025	Van Naarden Family Trust	F1
holding	LLY	Common Stock						4,302	13 Aug 2025	By spouse	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.